ImmuCell Corporation
General ticker "ICCC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $36.3M
ImmuCell Corporation does not follow the US Stock Market performance with the rate: -33.9%.
Estimated limits based on current volatility of 4.3%: low 4.44$, high 4.84$
Factors to consider:
- US accounted for 91.7% of revenue in the fiscal year ended 2022-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.25$, 6.68$]
- 2024-12-30 to 2025-12-30 estimated range: [4.10$, 7.87$]
Financial Metrics affecting the ICCC estimates:
- Negative: Non-GAAP EPS, $ of -0.75 <= 0.10
- Negative: Operating profit margin, % of -24.76 <= 1.03
- Negative: Operating cash flow per share per price, % of -11.72 <= 2.35
- Negative: negative Net income
- Positive: -0.96 < Investing cash flow per share, $ of -0.25
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
Short-term ICCC quotes
Long-term ICCC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $19.24MM | $18.57MM | $17.47MM |
| Operating Expenses | $18.99MM | $20.87MM | $23.22MM |
| Operating Income | $0.26MM | $-2.30MM | $-5.75MM |
| Non-Operating Income | $-0.33MM | $-0.19MM | $-0.02MM |
| Interest Expense | $0.31MM | $0.34MM | $0.00MM |
| R&D Expense | $4.17MM | $4.49MM | $4.39MM |
| Income(Loss) | $-0.07MM | $-2.49MM | $-5.77MM |
| Taxes | $0.01MM | $0.01MM | $0.00MM |
| Profit(Loss) | $-0.08MM | $-2.49MM | $-5.77MM |
| Stockholders Equity | $32.58MM | $30.38MM | $24.99MM |
| Inventory | $3.09MM | $6.04MM | $7.81MM |
| Assets | $44.47MM | $44.86MM | $43.81MM |
| Operating Cash Flow | $0.95MM | $-1.54MM | $-4.67MM |
| Capital expenditure | $2.61MM | $3.98MM | $1.89MM |
| Investing Cash Flow | $-1.60MM | $-3.96MM | $-1.89MM |
| Financing Cash Flow | $3.88MM | $1.11MM | $1.75MM |
| Earnings Per Share* | $-0.01 | $-0.32 | $-0.75 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.